E. R. Walker et al. / Tetrahedron Letters 46 (2005) 6537–6540
6539
(to A.G.M.B.), the Royal Society and the Wolfson
Foundation for a Royal Society—Wolfson Research
Merit Award (to A.G.M.B.), and the Wolfson Founda-
tion for establishing the Wolfson Centre for Organic
Chemistry in Medical Science at Imperial College
London.
B(OH)2
Br
12
13
a
References and notes
1. Greene, S. I. Antifungal Drug Ther. 1990, 23, 237.
2. Chu, M.; Truumees, I.; Mierzwa, R.; Terracciano, J.;
Patel, M.; Das, P. R.; Puar, M. S.; Chan, T. M.
Tetrahedron Lett. 1998, 39, 7649.
14
3. Kelly, T. R.; Jagoe, C. T.; Li, Q. J. Am. Chem. Soc. 1989,
111, 4522.
b
4. Mehta, G.; Shah, S. R.; Venkateswarlu, Y. Tetrahedron
1994, 50, 11729.
5. Rao, A. V. R.; Yadav, J. S.; Reddy, K. K.; Upender, V.
Tetrahedron Lett. 1991, 32, 5199.
6. Duthaler, R. O.; Heuberger, C.; Wegmann, U. H.;
Scherrer, V. Chimia 1985, 39, 174.
7. Campbell, A. D.; Raynham, T. M.; Taylor, R. J. K.
Synthesis 1998, 1707.
8. King, F. E.; Gilks, J. H.; Partridge, M. W. J. Chem. Soc.
1955, 4206.
15
Scheme 2. Reagents and conditions: (a) Pd2(dba)3, t-Bu3PHÆBF4, KF,
THF, 20 °C, 18 h (40%); (b) 11 (10 mol %), CH2Cl2, 20 °C, 24 h (50%).
9. Chaudhari, S. S.; Akamanchi, K. G. Synlett 1999, 1763.
10. Spectroscopic data: Compound 9: [a]D À3.09 (c 0.905,
CH3OH); IR (CHCl3 film) 3285, 1613, 1469 cmÀ1 1H
;
R2
R1
a - c
NMR (d8-toluene, 500 MHz, 80 °C): d 0.88 (t, J = 7.5 Hz,
3H), 0.98 (d, J = 6.7 Hz, 3H), 1.03 (t, J = 7.0 Hz, 3H),
1.07 (t, J = 7.0 Hz, 3H), 1.19 (m, 1H), 1.51 (m, 1H), 1.94
(m, 1H), 2.64 (s, 3H), 3.46 (diastereotopic m, 4H), 3.63 (s,
3H), 4.46 (d, J = 4.1 Hz, 1H), 4.74 (dd, J = 10.2, 4.1 Hz,
1H), 5.63 (s, 1H), 6.66 (dd, J = 7.5, 1.9 Hz, 1H), 6.69 (t,
J = 7.6 Hz, 1H), 6.77 (dd, J = 7.7, 1.9 Hz, 1H); 13C NMR
(CDCl3, 75 MHz): d 10.7, 15.2, 15.4, 15.6, 25.4, 32.3, 33.3,
57.3, 61.6, 63.6, 63.8, 103.0, 116.4, 118.3, 120.0, 124.8,
142.8, 149.4, 170.6; MS (ammonia, CI+) m/z 354, 308,
103; HRMS calcd for C19H32NO5: 354.2280 (M+H),
found: 354.2265 (M+H). Anal. Calcd for C19H31NO5: C,
64.56; H, 8.84; N, 3.96. Found: C, 64.49; H, 8.74; N,
3.82.
OH
OH
16
17
R1 = Me, NO2, CO2Me, OH; R2 = Me, NO2, CO2Me, OMe
R2
R2
d, e
f, g
OTf
R = Me, NO2, CO2Me, OMe
18
19
11. Kaufman, T. S. J. Chem. Soc., Perkin Trans. 1 1993, 403.
12. Perchonock, C. D.; Lantos, I.; Finkelstein, J. A.; Holden,
K. G. J. Org. Chem. 1980, 45, 1950.
Scheme 3. Reagents and conditions: (a) allyl bromide, K2CO3,
Me2CO, D, 16 h [R1 = NO2 (85%), CO2Me (78%), OH (60%)]; (b)
(R1 = OH only) MeI, K2CO3, Me2CO, D, 16 h (77%); (c) neat, 210 °C,
3 h, (R2 = NO2 170 °C, 45 h) [R2 = NO2 (76%), CO2Me (73%), OMe
(73%)]; (d) Tf2O, EtN-i-Pr2, CH2Cl2, À78 to 20 °C, 16 h [R2 = Me
(95%), NO2 (75%), CO2Me (91%), OMe (93%)]; (e) RhCl3, EtOH, D,
3.5 h [R2 = Me (46%), NO2 (45%), CO2Me (52%), OMe (48%)]; (f) 12,
Pd(PPh3)4, t-BuOK, DME, H2O, D, 17 h [R2 = Me (59%), NO2 (20%),
CO2Me (54%), OMe (55%)]; (g) 11 (10 mol %), CH2Cl2, D, 18 h
(P95%).
13. Spectroscopic data: Compound 10: [a]D +4.61 (c 1.09,
CH3OH); IR (neat) 3441, 2966, 1745, 1655, 1593,
1453 cmÀ1
;
1H NMR (CDCl3, 400 MHz): 0.97 (t,
J = 7.4 Hz, 3H), 1.27 (d, J = 6.7 Hz, 3H), 1.56 (m, 1H),
1.74 (m, 1H), 2.80 (m, 1H), 3.59 (s, 3H), 5.63 (s, 1H), 6.35
(s, 1H), 6.84 (d, J = 8.4 Hz, 1H), 7.24 (d, J = 8.4 Hz, 1H),
13.07 (s, 1H); 13C NMR (CDCl3, 100 MHz): d 11.8, 19.9,
29.3, 29.6, 36.4, 104.5, 110.6, 115.0, 122.7, 130.0, 141.1,
145.0, 146.2, 166.5; MS (ammonia, CI+) m/z 276 (impu-
rity), 262 (impurity), 248, 232, 218; HRMS calcd for
C14H18NO3: 248.1287 (M+H), found: 248.1282. Anal.
Calcd for C14H17NO3: C, 68.00; H, 6.93; N, 5.66. Found:
C, 67.91; H, 7.02; N, 5.59.
In summary, we have developed methods for the synthe-
sis of substituted isoquinolinones and ortho-substituted
phenanthrenes in good yields. Further studies on the
synthesis of Sch 56036 (1) will be reported in due course.
14. Iuliano, A.; Piccioli, P.; Fabbri, D. Org. Lett. 2004, 6,
3711.
15. Littke, A. F.; Dai, C.; Fu, G. C. J. Am. Chem. Soc. 2000,
122, 4020.
16. The samples of 14 and 15 showed spectroscopic charac-
teristics in agreement with published data; see Acheson, R.
M.; Lee, G. C. M. J. Chem. Soc., Perkin Trans. 1 1987,
2321; Ibrahim, Y. A.; Al-Awadi, N. A.; Kaul, K.
Tetrahedron 2001, 57, 7377.
Acknowledgements
We thank the EPSRC for their generous support of this
project, GlaxoSmithKline for the generous endowment